TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation.
TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation.
复制标题
DOI:
10.3390/ijms24010102
复制
发表时间:
2022-12-21
影响因子:
5.6
通讯作者:
Nishida, Motohiro
中科院分区:
文献类型:
--
作者:
Kato, Yuri;Nishiyama, Kazuhiro;Man Lee, Jae;Ibuki, Yuko;Imai, Yumiko;Noda, Takamasa;Kamiya, Noriho;Kusakabe, Takahiro;Kanda, Yasunari;Nishida, Motohiro
关键词:
Myocardial damage caused by the newly emerged coronavirus (SARS-CoV-2) infection is one of the key determinants of COVID-19 severity and mortality. SARS-CoV-2 entry to host cells is initiated by binding with its receptor, angiotensin-converting enzyme (ACE) 2, and the ACE2 abundance is thought to reflect the susceptibility to infection. Here, we report that ibudilast, which we previously identified as a potent inhibitor of protein complex between transient receptor potential canonical (TRPC) 3 and NADPH oxidase (Nox) 2, attenuates the SARS-CoV-2 spike glycoprotein pseudovirus-evoked contractile and metabolic dysfunctions of neonatal rat cardiomyocytes (NRCMs). Epidemiologically reported risk factors of severe COVID-19, including cigarette sidestream smoke (CSS) and anti-cancer drug treatment, commonly upregulate ACE2 expression level, and these were suppressed by inhibiting TRPC3-Nox2 complex formation. Exposure of NRCMs to SARS-CoV-2 pseudovirus, as well as CSS and doxorubicin (Dox), induces ATP release through pannexin-1 hemi-channels, and this ATP release potentiates pseudovirus entry to NRCMs and human iPS cell-derived cardiomyocytes (hiPS-CMs). As the pseudovirus entry followed by production of reactive oxygen species was attenuated by inhibiting TRPC3-Nox2 complex in hiPS-CMs, we suggest that TRPC3-Nox2 complex formation triggered by panexin1-mediated ATP release participates in exacerbation of myocardial damage by amplifying ACE2-dependent SARS-CoV-2 entry.
登录
查看更多内容
影响因子:
4.6
作者:
Kitajima N;Numaga-Tomita T;Watanabe M;Kuroda T;Nishimura A;Miyano K;Yasuda S;Kuwahara K;Sato Y;Ide T;Birnbaumer L;Sumimoto H;Mori Y;Nishida M
通讯作者:
Nishida M
影响因子:
37.8
作者:
Bozkurt, Biykem;Kamat, Ishan;Hotez, Peter J.
通讯作者:
Hotez, Peter J.
影响因子:
5.8
作者:
Cheema PS;Nandi D;Nag A
通讯作者:
Nag A
影响因子:
82.9
作者:
Kuba K;Imai Y;Rao S;Gao H;Guo F;Guan B;Huan Y;Yang P;Zhang Y;Deng W;Bao L;Zhang B;Liu G;Wang Z;Chappell M;Liu Y;Zheng D;Leibbrandt A;Wada T;Slutsky AS;Liu D;Qin C;Jiang C;Penninger JM
通讯作者:
Penninger JM
DOI:
10.1016/j.bbrc.2020.06.020
发表时间:
2020-08-20
影响因子:
3.1
作者:
Fujita, Ryosuke;Hino, Masato;Kusakabe, Takahiro
通讯作者:
Kusakabe, Takahiro